A R T I C L E S
Hirao et al.
Synthesis of 1-(2-Deoxy-â-D-ribofuranosyl)imidazolin-2-one (2).
A mixture of imidazolin-2-one29 (505 mg, 6 mmol), hexamethyldisi-
lazane (HMDS) (20 mL, 20 mmol), ammonium sulfate (60 mg, 0.45
mmol), and dichloroethane (5 mL) was refluxed for 2 h, and then the
excess HMDS and dichloroethane were removed from the mixture by
evaporation. The residue was dissolved in acetonitrile (10 mL), and
the solution was mixed with an acetonitrile solution (10 mL) containing
1-chloro-2-deoxy-3,5-di-O-toluoyl-R-D-erythropentofuranose (1.56 g,
4 mmol). To the mixture was added a solution of SnCl4 (0.1 mL, 0.85
mmol) in acetonitrile (5 mL) dropwise at -15 °C, and the solution
was stirred for 1 h at room temperature. The reaction mixture was
poured onto a dichloromethane (100 mL) and saturated NaHCO3
solution (100 mL). The organic layer was washed with a saturated
sodium chloride solution (100 mL), dried with MgSO4, and evaporated
in vacuo. The product was purified by silica gel column chromatography
to give the fully protected mixture of R- and â-isomers (1.31 g, 75%).
The mixture was dissolved in methanolic ammonia (100 mL), stirred
for 12 h at room temperature, and evaporated. The residue was dissolved
in H2O, and each isomer (â-isomer, 155 mg; R-isomer, 193 mg) was
separated by reversed-phase HPLC (Waters Microbond Sphere model
C18, with a gradient from 0% to 7.5% (15 min) CH3CN in H2O).
1-(2-Deoxy-3,5-di-O-tetraisopropyldisiloxanyl-â-D-ribofuranosyl)-
imidazolin-2-one. To a stirred solution of 2 (73 mg, 0.36 mmol) in
DMF (1.8 mL) and pyridine (278 µL) in an ice-cold bath was added
1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane (111 µL, 0.36 mmol). The
reaction mixture was stirred at room temperature for 12 h and was
partitioned with 5% NaHCO3 and EtOAc. The organic layer was washed
with 5% NaHCO3 followed by saturated NaCl, dried over Na2SO4, and
concentrated in vacuo. The product (120 mg, 78%) was purified from
the residue by silica gel column chromatography (2% MeOH in CH2-
Cl2).
1-(2-Deoxy-3,5-di-O-tetraisopropyldisiloxanyl-â-D-ribofuranosyl)-
2-diphenylcarbamoyloxyimidazole. To a stirred solution of 1-(2-
deoxy-3,5-di-O-tetraisopropyldisiloxanyl-â-D-ribofuranosyl)imidazolin-
2-one (120 mg, 0.27 mmol) and diphenylcarbamoyl chloride (150 mg,
2.4 equiv) in pyridine (2.7 mL) was added N,N-diisopropylethylamine
(57 µL, 1.2 equiv). The solution was stirred at room temperature for
12 h and was partitioned with CH2Cl2 and water after the addition of
MeOH. The organic layer was washed with 5% NaHCO3 three times,
dried over Na2SO4, and concentrated in vacuo. The product (100 mg,
60%) was purified from the residue by silica gel column chromatog-
raphy (1% MeOH in CH2Cl2).
1-(2-Deoxy-â-D-ribofuranosyl)-2-diphenylcarbamoyloxyimida-
zole (3). To a stirred solution of 1-(2-deoxy-3,5-di-O-tetraisopropyl-
disiloxanyl-â-D-ribofuranosyl)-2-diphenylcarbamoyloxyimidazole (100
mg, 0.16 mmol) in THF (1.6 mL) was added 1 M TBAF in a THF
solution (0.24 mL, 1.5 equiv). The reaction mixture was stirred at room
temperature for 30 min and was partitioned with EtOAc and water.
The organic layer was washed with saturated NaCl, dried over Na2-
SO4, and concentrated in vacuo. The product (60 mg, 96%) was purified
by silica gel column chromatography (5% MeOH in CH2Cl2).
1-[2-Deoxy-5-O-(4,4′-dimethoxytrityl)-â-D-ribofuranosyl]-2-diphe-
nylcarbamoyloxyimidazole. A quantity of 1-(2-deoxy-â-D-ribofura-
nosyl)-2-diphenylcarbamoyloxyimidazole (60 mg, 0.15 mmol) was
coevaporated with dry pyridine three times. The residue was dissolved
in pyridine (1.5 mL) with 4,4′-dimethoxytrityl chloride (52 mg, 1.0
equiv), and the solution was stirred at room temperature for 12 h. Water
was added to the solution, and the product was extracted with EtOAc.
The organic layer was washed with 5% NaHCO3 twice and then with
saturated NaCl, dried over Na2SO4, and concentrated in vacuo. The
product was purified by silica gel column chromatography (2% MeOH
in CH2Cl2) to give the dimethoxytrityl derivative (92 mg, 86%).
1-[2-Deoxy-5-O-(4,4′-dimethoxytrityl)-â-D-ribofuranosyl]-2-diphe-
nylcarbamoyloxyimidazole 2-Cyanoethyl-N,N′-diisopropylamino-
phosphoramidite (4). A quantity of 1-[2-deoxy-5-O-(4,4′-dimethox-
ytrityl)-â-D-ribofuranosyl]-2-diphenylcarbamoyloxyimidazole (92 mg,
0.13 mmol) was coevaporated with dry pyridine and dry THF three
times each, and was dissolved in THF (650 µL). To the solution were
added diisopropylethylamine (34 µL, 1.5 equiv) and 2-cyanoethyl-N,N′-
diisopropylamino-chlorophosphoramidite (44 µL, 1.5 equiv). The
reaction mixture was stirred at room temperature for 1 h. After the
addition of MeOH (50 µL), the mixture was diluted with EtOAc/TEA
(10 mL, 20:1, v/v). The mixture was washed with 5% NaHCO3,
followed by saturated NaCl three times. The organic layer was dried
over Na2SO4 and concentrated in vacuo. The product was purified on
a silica gel column, which was eluted with hexane:EtOAc (3:2, v/v)
containing 2% TEA, to give the amidite (100 mg, 86%).
Synthesis of 1-(2-Deoxy-â-D-ribofuranosyl)imidazolin-2-one 5′-Tri-
phosphate (dzTP, 5) and 1-(â-D-Ribofuranosyl)imidazolin-2-one 5′-
Triphosphate (zTP). The ribonucleoside of z was synthesized accord-
ing to the literature procedure.17 To a solution of the 2′-deoxyribonu-
cleoside of z or the ribonucleoside of z (0.1 mmol) and a proton sponge
(33 mg, 0.15 mmol), in trimethyl phosphate (500 µL), was added POCl3
(12 µL, 0.13 mmol) at 0 °C.30 The reaction mixture was stirred at 0 °C
for 2 h (for the 2′-deoxyribonucleoside of z), or for 6 h (for the
ribonucleoside of z). Tri-n-butylamine (120 µL, 0.5 mmol) was added
to the reaction mixture, followed by 0.5 M bis(tributylammonium)-
pyrophosphate in a DMF solution (1.0 mL, 0.5 mmol). After 5 min,
the reaction was quenched by the addition of 0.5 M triethylammonium
bicarbonate (TEAB, 500 µL). The resulting crude product was purified
by DEAE Sephadex A-25 column chromatography (eluted by a linear
gradient of 50 mM to 1 M TEAB), and then by C18-HPLC (eluted by
a gradient of 0% to 30% CH3CN in 100 mM triethylammonium acetate).
Thermal Denaturation. The absorbance at 260 nm of the DNA
fragments was monitored as a function of temperature (15-65 °C) on
a Beckman DU650 spectrophotometer. The duplexes of 5′-GGTAAC-
NATGCG and 5′-CGCATN′GTTACC (N ) s or natural bases and N′
) z, y, or natural bases) were dissolved in 10 mM sodium phosphate
(pH 7.0), 100 mM NaCl, and 0.1 mM EDTA, to give a duplex
concentration of 5 µM. Tm values were calculated by the first derivatives
of the melting curves.
Single-Nucleotide Insertion Experiments. Steady-state kinetics for
single-nucleotide insertions were carried out according to the litera-
ture,31,32 using the templates shown in Table 1. Primers were 5′-labeled
by using [γ-32P]ATP and T4 polynucleotide kinase. Primer-template
duplexes (10 µM) were annealed, in a buffer containing 100 mM Tris-
HCl (pH 7.5), 20 mM MgCl2, 2 mM DTT, and 0.1 mg/mL bovine
serum albumin, by heating at 95 °C and slow-cooling to 4 °C. The
duplex solution (5 µL) was mixed with 2 µL of a solution containing
the exonuclease-deficient Klenow fragment (Amersham USB, OH)
diluted in a buffer containing 50 mM potassium phosphate (pH 7.0), 1
mM DTT, and 50% glycerol, and was incubated at 37 °C for more
than 2 min. Reactions were initiated by adding 3 µL of a dNTP solution
to the DNA-enzyme mixture at 37 °C. The amount of polymerase
used (5-50 nM), the reaction time (1-20 min), and the gradient
concentration of dNTP (0.6-2400 µM) were adjusted to give reaction
extents of 25% or less. Reactions were quenched by adding 10 µL of
a dye solution containing 0.05% BPB, 89 mM Tris-borate, 2 mM
EDTA, and 10 M urea, and the mixtures were immediately heated at
75 °C for 3 min. The products were analyzed on a 15-20%
polyacrylamide gel containing 7 M urea. The reaction extents were
measured with a Bio-imaging analyzer (Fuji BAS 2500). Relative
velocities (V0) were calculated as the extents of the reaction divided by
the reaction time, and were normalized to the enzyme concentration
(20 nM) for the various enzyme concentrations used. The kinetic
(30) Kova´cs, T.; O¨ tvo¨s, L. Tetrahedron Lett. 1988, 29, 4525-4528.
(31) Petruska, J.; Goodman, M. F.; Boosalis, M. S.; Sowers, L. C.; Cheong, C.;
Tinoco, I. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 6252.
(32) Goodman, M. F.; Creighton, S.; Bloom, L. B.; Petruska, J. Crit. ReV.
(29) Hilbert, G. E. J. Am. Chem. Soc. 1932, 54, 3413.
Biochem. Mol. Biol. 1993, 28, 83.
9
13304 J. AM. CHEM. SOC. VOL. 126, NO. 41, 2004